ライフサイエンスコーパス: necrotizing myopathy

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 s observed in only 1 of 187 patients without necrotizing myopathy.

2 entify novel autoantibodies in patients with necrotizing myopathy.

3 rodiagnostic findings were consistent with a necrotizing myopathy.

4 ntly identified statin-associated autoimmune-necrotizing myopathy.

5 ents with dermatomyositis and the autoimmune necrotizing myopathies.

6 ated with dermatomyositis and the autoimmune necrotizing myopathies.

7 ients with statin-associated immune-mediated necrotizing myopathy and, less commonly, in statin-unexp

8 ients with dermatomyositis, polymyositis, or necrotizing myopathy, and 0/20 (0%) age-matched healthy

9 In a subgroup, an autoimmune necrotizing myopathy develops that persists after discon

10 One patient with severe necrotizing myopathy died.

11 ren with profiles from children with a known necrotizing myopathy (Duchenne muscular dystrophy), as w

12 The underlying immune response in necrotizing myopathy has not yet been addressed in detai

13 Immune-mediated necrotizing myopathies (IMNM) may be associated with eit

14 Immune-mediated necrotizing myopathy (IMNM) is considered one of the idi

15 in use is associated with an immune-mediated necrotizing myopathy (IMNM), with autoantibodies that re

16 Necrotizing Myopathy is a poorly studied subacute myopat

17 t evidence now suggests that immune-mediated necrotizing myopathy is not one disease, but can be divi

18 However, the etiology of a necrotizing myopathy is often obscure, and the question

19 antibodies found in patients with autoimmune necrotizing myopathies recognize signal recognition part

20 MB in juvenile DM that focuses on extent of necrotizing myopathy, severity of vasculopathy, and feat

21 The heterogeneous group of necrotizing myopathies shows a varying amount of necroti

22 A decade ago, immune-mediated necrotizing myopathy was recognized as a distinct form o

23 ed immune response in most of the autoimmune necrotizing myopathies, which may guide therapeutic opti

24 cificity defines a subgroup of patients with necrotizing myopathy who previously were considered to b

25 that statins may trigger an immune-mediated necrotizing myopathy with many features of polymyositis.

26 in dermatomyositis and in the rare disorder, necrotizing myopathy with pipestem capillaries.

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。